Related references
Note: Only part of the references are listed.A Comprehensive Review of Sequencing and Combination Strategies of Targeted Agents in Metastatic Colorectal Cancer
Kristen K. Ciombor et al.
ONCOLOGIST (2018)
Progranulin and its biological effects in cancer
Fabian Arechavaleta-Velasco et al.
MEDICAL ONCOLOGY (2017)
Progranulin Plays a Central Role in Host Defense during Sepsis by Promoting Macrophage Recruitment
Zhixin Song et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Progranulin as a predictive factor of response to chemotherapy in advanced biliary tract carcinoma
Jong-Ho Kim et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Microsatellite Instability Status of Interval Colorectal Cancers in a Korean Population
Kil Woo Lee et al.
GUT AND LIVER (2016)
Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin
Simone Buraschi et al.
ONCOTARGET (2016)
Diabetes mellitus and the risk of bladder cancer: an Italian case-control study
F. Turati et al.
BRITISH JOURNAL OF CANCER (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
GP88 (progranulin): a novel tissue and circulating biomarker for non small cell lung carcinoma
Martin J. Edelman et al.
HUMAN PATHOLOGY (2014)
Diabetes Mellitus and Ovarian Cancer Risk A Systematic Review and Meta-Analysis of Observational Studies
Jung-Yun Lee et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Plasma Progranulin Concentrations Are Increased in Patients with Type 2 Diabetes and Obesity and Correlated with Insulin Resistance
Hua Qu et al.
MEDIATORS OF INFLAMMATION (2013)
PGRN is a Key Adipokine Mediating High Fat Diet-Induced Insulin Resistance and Obesity through IL-6 in Adipose Tissue
Toshiya Matsubara et al.
CELL METABOLISM (2012)
Progranulin as a Prognostic Biomarker for Breast Cancer Recurrence in Patients Who Had Hormone Receptor-Positive Tumors: A Cohort Study
Dong Hoe Koo et al.
PLOS ONE (2012)
Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma
Ginette Serrero et al.
BREAST CANCER RESEARCH (2012)
Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China
F. M. Shebl et al.
BRITISH JOURNAL OF CANCER (2011)
Upregulation of progranulin by Helicobacter pylori in human gastric epithelial cells via p38MAPK and MEK1/2 signaling pathway: role in epithelial cell proliferation and migration
Hongyan Wang et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2011)
Granulin-Epithelin Precursor and ATP-Dependent Binding Cassette (ABC)B5 Regulate Liver Cancer Cell Chemoresistance
Siu Tim Cheung et al.
GASTROENTEROLOGY (2011)
Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers
Jasmine J. Han et al.
GYNECOLOGIC ONCOLOGY (2011)
Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice
Moshe Elkabets et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-Analysis
Kimberly S. Peairs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in Mice
Wei Tang et al.
SCIENCE (2011)
Diabetes and Cancer: A Consensus Report
Edward Giovannucci et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma
Jenny C. Ho et al.
HEPATOLOGY (2008)
Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplilications, and KRAS mutations on survival of pancreatic adenocarcinoma
Jeeyun Lee et al.
CANCER (2007)
Clinically confirmed type 2 diabetes Mellitus and colorectal cancer risk: A population-based, retrospective cohort study
Paul J. Limburg et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma
B Davidson et al.
CANCER (2004)
Expression of PC-cell-derived growth factor in benign and malignant human breast epithelium
G Serrero et al.
HUMAN PATHOLOGY (2003)
Share Paper
